SPONSOR
Vanda Pharmaceuticals
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology DisordersGene Mutations and Other Alterations NecDry Eye
NCT06701396 Phase 3
Recruiting
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Sleep Wake Disorders
NCT06296966 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Dry Eye